Stocklytics Platform
Asset logo for symbol MRNS
Marinus Pharmaceuticals
MRNS60
$0.53arrow_drop_down0.35%-$0.00
Penny Stock
Asset logo for symbol MRNS
MRNS60

$0.53

arrow_drop_down0.35%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Marinus Pharmaceuticals (MRNS) Stocklytics Forecast

Marinus Pharmaceuticals Inc (MRNS) is a biopharmaceutical company that focuses on the development and commercialization of innovative therapeutics to treat epilepsy and other neurological disorders. With a strong pipeline of potential drug candidates, Marinus Pharmaceuticals is well-positioned for future growth and success.
When it comes to forecasting the stock price for Marinus Pharmaceuticals Inc (MRNS), it is important to consider various factors. AI and machine learning algorithms can play a crucial role in predicting future stock prices. These advanced technologies analyze historical data, market trends, and other relevant factors to generate predictions.
add Marinus Pharmaceuticals  to watchlist

Keep an eye on Marinus Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Marinus Pharmaceuticals (MRNS) stock?

Analysts have set a target price of $25.22 for Marinus Pharmaceuticals (MRNS), based on forecasts from 27 analysts. The predicted price range extends from a high of $50 to a low of $13. This represents a potential increase of up to 9.18K% and a decrease of 2.31K% from the current price of $0.54. These forecasts are as of 2020 Nov 25.
help

What are the analyst ratings for Marinus Pharmaceuticals (MRNS) stock?

The analyst ratings for Marinus Pharmaceuticals (MRNS) are distributed as follows: 2 analysts recommend buying, 7 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 9 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Marinus Pharmaceuticals .
help

What is the AI price prediction for Marinus Pharmaceuticals (MRNS) stock?

At present, there is no AI or machine-learning-based price prediction available for Marinus Pharmaceuticals (MRNS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level